Investor Stock List
Ranked #3,450 of 8,699 institutional investors

Foresite Capital Management VI LLC

West Hollywood, CA

$542M
US stock portfolio at live prices · today −$75K (−0.01%)
Live prices, last trade 11:05 AM ET
Value at quarter end (Q3 2026)
$566M
Change from Q2 2026
−$76.2M (−11.86%)
Positions
19 · 3 new, 2 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$33.0M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
CGON 31.8%KRSA 9.90%SPTX 6.05%DNLI 5.57%LTGO 5.30%
StockSharesValue, live% of portfoliovs Q2 2026
CGON CG Oncology, Inc.2,109,574$173M31.8%Reduced −11%
KRSA Korsana Biosciences, Inc.1,431,660$53.6M9.90%New
SPTX Seaport Therapeutics, Inc.1,779,521$32.8M6.05%Unchanged
DNLI Denali Therapeutics Inc.1,617,771$30.2M5.57%Added +16%
LTGO Latigo Biotherapeutics, Inc.2,203,800$28.7M5.30%New
PBLS Parabilis Medicines, Inc.999,044$27.9M5.14%Unchanged
AGIO Agios Pharmaceuticals, Inc.827,128$23.6M4.35%Added +5%
VSTM Verastem, Inc.3,146,631$20.7M3.82%Unchanged
CRVS Corvus Pharmaceuticals, Inc.1,831,233$17.7M3.27%Unchanged
ALMS Alumis Inc.4,247,670$17.5M3.24%Unchanged
KYMR Kymera Therapeutics, Inc.146,332$16.9M3.11%Unchanged
JBIO Jade Biosciences, Inc.886,667$13.6M2.50%Unchanged
HNGE Hinge Health, Inc.108,100$11.5M2.13%Reduced −51%
OBX Obsidian Therapeutics, Inc.916,063$10.9M2.02%New
AURA Aura Biosciences, Inc.1,333,334$9.1M1.68%Unchanged
BEAM Beam Therapeutics Inc.330,000$7.1M1.31%Unchanged
AVBP ArriVent BioPharma, Inc.490,341$5.4M1.00%Added +63%
IRON Disc Medicine, Inc.68,470$5.1M0.94%Added +6,959%
NERV Minerva Neurosciences, Inc.1,985,584$4.1M0.76%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
CLDX Celldex Therapeutics, Inc.879,713$24.2M
KLRA Kailera Therapeutics, Inc.37,500$432K